Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19724920)

  • 1. The differential cell signaling effects of two positional isomers of the anticancer NO-donating aspirin.
    Hua A; Mackenzie GG; Rigas B
    Int J Oncol; 2009 Oct; 35(4):837-44. PubMed ID: 19724920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide-donating aspirin inhibits colon cancer cell growth via mitogen-activated protein kinase activation.
    Hundley TR; Rigas B
    J Pharmacol Exp Ther; 2006 Jan; 316(1):25-34. PubMed ID: 16169935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positional isomerism markedly affects the growth inhibition of colon cancer cells by nitric oxide-donating aspirin in vitro and in vivo.
    Kashfi K; Borgo S; Williams JL; Chen J; Gao J; Glekas A; Benedini F; Del Soldato P; Rigas B
    J Pharmacol Exp Ther; 2005 Mar; 312(3):978-88. PubMed ID: 15528453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positional isomerism markedly affects the growth inhibition of colon cancer cells by NOSH-aspirin: COX inhibition and modeling.
    Vannini F; Chattopadhyay M; Kodela R; Rao PPN; Kashfi K
    Redox Biol; 2015 Dec; 6():318-325. PubMed ID: 26319435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positional isomers of aspirin are equally potent in inhibiting colon cancer cell growth: differences in mode of cyclooxygenase inhibition.
    Kodela R; Chattopadhyay M; Goswami S; Gan ZY; Rao PP; Nia KV; Velázquez-Martínez CA; Kashfi K
    J Pharmacol Exp Ther; 2013 Apr; 345(1):85-94. PubMed ID: 23349335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphoaspirin (MDC-43), a novel benzyl ester of aspirin, inhibits the growth of human cancer cell lines more potently than aspirin: a redox-dependent effect.
    Zhao W; Mackenzie GG; Murray OT; Zhang Z; Rigas B
    Carcinogenesis; 2009 Mar; 30(3):512-9. PubMed ID: 19136474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitro-aspirin inhibits MCF-7 breast cancer cell growth: effects on COX-2 expression and Wnt/beta-catenin/TCF-4 signaling.
    Nath N; Vassell R; Chattopadhyay M; Kogan M; Kashfi K
    Biochem Pharmacol; 2009 Nov; 78(10):1298-304. PubMed ID: 19576865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide-donating aspirin induces apoptosis in human colon cancer cells through induction of oxidative stress.
    Gao J; Liu X; Rigas B
    Proc Natl Acad Sci U S A; 2005 Nov; 102(47):17207-12. PubMed ID: 16282376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation-stimulated ERK1/2 and JNK1/2 signaling can promote cell cycle progression in human colon cancer cells.
    Carón RW; Yacoub A; Mitchell C; Zhu X; Hong Y; Sasazuki T; Shirasawa S; Hagan MP; Grant S; Dent P
    Cell Cycle; 2005 Mar; 4(3):456-64. PubMed ID: 15655348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct effects of methylseleninic acid versus selenite on apoptosis, cell cycle, and protein kinase pathways in DU145 human prostate cancer cells.
    Jiang C; Wang Z; Ganther H; Lü J
    Mol Cancer Ther; 2002 Oct; 1(12):1059-66. PubMed ID: 12481429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells.
    Wang F; Li H; Yan XG; Zhou ZW; Yi ZG; He ZX; Pan ST; Yang YX; Wang ZZ; Zhang X; Yang T; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():575-601. PubMed ID: 25632225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth inhibition of human colon cancer cells by nitric oxide (NO)-donating aspirin is associated with cyclooxygenase-2 induction and beta-catenin/T-cell factor signaling, nuclear factor-kappaB, and NO synthase 2 inhibition: implications for chemoprevention.
    Williams JL; Nath N; Chen J; Hundley TR; Gao J; Kopelovich L; Kashfi K; Rigas B
    Cancer Res; 2003 Nov; 63(22):7613-8. PubMed ID: 14633677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanism of action of nitric oxide-donating aspirin.
    Kashfi K; Rigas B
    Biochem Biophys Res Commun; 2007 Jul; 358(4):1096-101. PubMed ID: 17512900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide-donating aspirin inhibits beta-catenin/T cell factor (TCF) signaling in SW480 colon cancer cells by disrupting the nuclear beta-catenin-TCF association.
    Nath N; Kashfi K; Chen J; Rigas B
    Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12584-9. PubMed ID: 14566053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo.
    Nath N; Chattopadhyay M; Rodes DB; Nazarenko A; Kodela R; Kashfi K
    Molecules; 2015 Jul; 20(7):12481-99. PubMed ID: 26184135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NOSH-Aspirin Inhibits Colon Cancer Cell Growth: Effects Of Positional Isomerism.
    Vannini F; Kodela R; Chattopadhyay M; Kashfi K
    Redox Biol; 2015 Aug; 5():421. PubMed ID: 28162291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin inhibits p44/42 mitogen-activated protein kinase and is protective against hypoxia/reoxygenation neuronal damage.
    Vartiainen N; Goldsteins G; Keksa-Goldsteine V; Chan PH; Koistinaho J
    Stroke; 2003 Mar; 34(3):752-7. PubMed ID: 12624303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide-donating aspirin induces G2/M phase cell cycle arrest in human cancer cells by regulating phase transition proteins.
    Gao L; Williams JL
    Int J Oncol; 2012 Jul; 41(1):325-30. PubMed ID: 22552812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
    Zhang YX; Kong CZ
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Cyclin-dependent kinase inhibitor CYC202 (R-roscovitine) inhibits retinoblastoma protein phosphorylation, causes loss of Cyclin D1, and activates the mitogen-activated protein kinase pathway.
    Whittaker SR; Walton MI; Garrett MD; Workman P
    Cancer Res; 2004 Jan; 64(1):262-72. PubMed ID: 14729633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.